ときわバイオ株式会社

English / Japanese

TOKIWA-Bio is a gene-cell therapy and regenerative medicine product development company which has developed Stealth RNA Vector(SRV) an innovative technology of gene expression system. The SRV is the world-first RNA vector stabilized in cytoplasm and capable to install at least 10 genes on single vector.

Business Model

A company follows business model; making in-house products and sells production, co-research and development programs(possible for aquisition of know-how and continuation of technical innovation), alliance for drug discovery(contribution at R&D stage of the pharmaceutical company), and technology access program.